Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
60.33
-0.70 (-1.15%)
At close: Dec 26, 2025
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 37.21 billion as of December 26, 2025. Its market cap has increased by 160.16% in one year.
Market Cap
37.21B
Enterprise Value
35.45B
Revenue
1.37B
Ranking
n/a
PE Ratio
43.36
Stock Price
60.33
Market Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 37.21B, an increase of 11.62%. That is a compound annual growth rate of 2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 37.21B | 181.65% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | 15.19B | -54.44% |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 405.29B |
| WuXi AppTec | 273.05B |
| Shenzhen Mindray Bio-Medical Electronics | 241.87B |
| Sichuan Biokin Pharmaceutical | 139.78B |
| Shanghai United Imaging Healthcare | 106.87B |
| Aier Eye Hospital Group | 103.46B |
| Zhangzhou Pientzehuang Pharmaceutical., | 102.68B |
| Yunnan Baiyao Group Co.,Ltd | 101.17B |